Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (361-370 of 460) with videos related to

Pageof 46
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Cell|September 22, 2020
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T ImmunotherapiesKevin R Parker, Denis Migliorini, Eric Perkey, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Nature Biomedical Engineering|October 1, 2025
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
The New England Journal of Medicine|June 24, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell LymphomasMarco Ruella, Luca Paruzzo, Emeline R Chong, et al.
Pageof 46

Showing results (361-370 of 460) with videos related to

Sort By:
Pageof 46
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Immunity|September 30, 2023
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsSangya Agarwal, M Angela Aznar, Andrew J Rech, et al.
Cell|September 22, 2020
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T ImmunotherapiesKevin R Parker, Denis Migliorini, Eric Perkey, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Nature Biomedical Engineering|October 1, 2025
Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
The New England Journal of Medicine|June 24, 2026
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell LymphomasMarco Ruella, Luca Paruzzo, Emeline R Chong, et al.
Pageof 46